vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Madison Square Garden Entertainment Corp. (MSGE). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $424.8M, roughly 1.2× Madison Square Garden Entertainment Corp.). Madison Square Garden Entertainment Corp. runs the higher net margin — 21.8% vs 6.8%, a 15.0% gap on every dollar of revenue. On growth, Madison Square Garden Entertainment Corp. posted the faster year-over-year revenue change (12.5% vs -1.7%). Over the past eight quarters, Madison Square Garden Entertainment Corp.'s revenue compounded faster (48.9% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Madison Square Garden Sports Corp. is an American sports holding company based in New York City.
MD vs MSGE — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $424.8M |
| Net Profit | $33.7M | $92.7M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 38.6% |
| Net Margin | 6.8% | 21.8% |
| Revenue YoY | -1.7% | 12.5% |
| Net Profit YoY | 10.5% | 22.2% |
| EPS (diluted) | $0.40 | $1.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $424.8M | ||
| Q3 25 | $492.9M | $154.1M | ||
| Q2 25 | $468.8M | $145.1M | ||
| Q1 25 | $458.4M | $206.0M | ||
| Q4 24 | $502.4M | $377.6M | ||
| Q3 24 | $511.2M | $134.1M | ||
| Q2 24 | $504.3M | $177.6M | ||
| Q1 24 | $495.1M | $191.6M |
| Q4 25 | $33.7M | $92.7M | ||
| Q3 25 | $71.7M | $-21.7M | ||
| Q2 25 | $39.3M | $-27.2M | ||
| Q1 25 | $20.7M | $8.0M | ||
| Q4 24 | $30.5M | $75.9M | ||
| Q3 24 | $19.4M | $-19.3M | ||
| Q2 24 | $-153.0M | $66.9M | ||
| Q1 24 | $4.0M | $2.8M |
| Q4 25 | 9.9% | 38.6% | ||
| Q3 25 | 13.8% | -19.3% | ||
| Q2 25 | 12.8% | -17.7% | ||
| Q1 25 | 7.0% | 13.3% | ||
| Q4 24 | 7.8% | 36.8% | ||
| Q3 24 | 6.6% | -13.8% | ||
| Q2 24 | -31.3% | -5.0% | ||
| Q1 24 | 3.2% | 8.8% |
| Q4 25 | 6.8% | 21.8% | ||
| Q3 25 | 14.5% | -14.0% | ||
| Q2 25 | 8.4% | -18.7% | ||
| Q1 25 | 4.5% | 3.9% | ||
| Q4 24 | 6.1% | 20.1% | ||
| Q3 24 | 3.8% | -14.4% | ||
| Q2 24 | -30.3% | 37.7% | ||
| Q1 24 | 0.8% | 1.5% |
| Q4 25 | $0.40 | $1.94 | ||
| Q3 25 | $0.84 | $-0.46 | ||
| Q2 25 | $0.46 | $-0.56 | ||
| Q1 25 | $0.24 | $0.17 | ||
| Q4 24 | $0.37 | $1.56 | ||
| Q3 24 | $0.23 | $-0.40 | ||
| Q2 24 | $-1.84 | $1.32 | ||
| Q1 24 | $0.05 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $157.1M |
| Total DebtLower is stronger | $570.5M | $554.6M |
| Stockholders' EquityBook value | $865.9M | $36.0M |
| Total Assets | $2.2B | $1.8B |
| Debt / EquityLower = less leverage | 0.66× | 15.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $157.1M | ||
| Q3 25 | $340.1M | $29.9M | ||
| Q2 25 | $224.7M | $43.0M | ||
| Q1 25 | $99.0M | $89.0M | ||
| Q4 24 | $229.9M | $54.9M | ||
| Q3 24 | $103.8M | $37.3M | ||
| Q2 24 | $19.4M | $33.3M | ||
| Q1 24 | $8.0M | $28.0M |
| Q4 25 | $570.5M | $554.6M | ||
| Q3 25 | $577.2M | $581.7M | ||
| Q2 25 | $583.9M | $568.8M | ||
| Q1 25 | $590.5M | $577.4M | ||
| Q4 24 | $597.1M | $584.7M | ||
| Q3 24 | — | $647.0M | ||
| Q2 24 | — | $599.2M | ||
| Q1 24 | — | $602.5M |
| Q4 25 | $865.9M | $36.0M | ||
| Q3 25 | $890.7M | $-65.8M | ||
| Q2 25 | $833.8M | $-13.3M | ||
| Q1 25 | $789.2M | $9.5M | ||
| Q4 24 | $764.9M | $10.3M | ||
| Q3 24 | $732.5M | $-48.7M | ||
| Q2 24 | $706.5M | $-23.2M | ||
| Q1 24 | $856.2M | $-94.6M |
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $2.1B | $1.7B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $2.2B | $1.6B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.6B | ||
| Q1 24 | $2.2B | $1.5B |
| Q4 25 | 0.66× | 15.40× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | 60.61× | ||
| Q4 24 | 0.78× | 56.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $164.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $164.4M | ||
| Q3 25 | $137.3M | $19.8M | ||
| Q2 25 | $137.2M | $-27.0M | ||
| Q1 25 | $-117.5M | $56.8M | ||
| Q4 24 | $133.0M | $112.9M | ||
| Q3 24 | $91.8M | $-27.4M | ||
| Q2 24 | $107.0M | $212.0K | ||
| Q1 24 | $-125.2M | $5.8M |
| Q4 25 | 3.39× | 1.77× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | 7.07× | ||
| Q4 24 | 4.36× | 1.49× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | -31.03× | 2.08× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MSGE
| Ticketing And Venue License Fee Revenues | $263.5M | 62% |
| Food Beverage And Merchandise Revenues | $64.3M | 15% |
| Related Party | $43.9M | 10% |
| Arena Licensing Fees And Other Leasing Revenue | $35.2M | 8% |
| Other | $15.9M | 4% |
